LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 1337 | 685 | 1.9502 | 1.3106 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 185 | 685 | 0.2699 | 0.5068 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 1326 | 685 | 1.9342 | 1.3065 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 8 | 685 | 0.0117 | -0.2358 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 1210 | 685 | 1.7650 | 1.2613 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 42 | 838 | 0.0501 | 0.0879 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 1140 | 838 | 1.3592 | 1.1288 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 38 | 838 | 0.0453 | 0.0660 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 1461 | 838 | 1.7420 | 1.2390 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 476 | 838 | 0.5675 | 0.7824 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 1406 | 838 | 1.6764 | 1.2216 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 10 | 838 | 0.0119 | -0.1875 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 17.28 | 27.76 | 1290 | 838 | 1.5381 | 1.1830 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 69 | 941 | 0.0733 | 0.1962 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 1301 | 941 | 1.3824 | 1.1315 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 39 | 941 | 0.0414 | 0.0692 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 1594 | 941 | 1.6937 | 1.2184 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 519 | 941 | 0.5515 | 0.7790 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 1554 | 941 | 1.6512 | 1.2074 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 24 | 941 | 0.0255 | -0.0282 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.98 | 27.76 | 1415 | 941 | 1.5035 | 1.1671 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 93 | 1119 | 0.0831 | 0.2545 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 1387 | 1119 | 1.2395 | 1.0822 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 53 | 1119 | 0.0474 | 0.1289 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 1759 | 1119 | 1.5719 | 1.1770 | MN20160318_Q01 | J19 |